Dengue Virus, Type 2, NS1 (DEN2)
Catalog No : USB-D2800-13N
579.33€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
Product name | Dengue Virus, Type 2, NS1 (DEN2) | ||
---|---|---|---|
Catalog No | USB-D2800-13N | ||
Supplier’s Catalog No | D2800-13N | ||
Supplier | US Biologicals | ||
Source antigen | E. coli | ||
Reactivity | |||
Cross reactivity | |||
Applications | |||
Molecular weight |
Storage | -20°C | ||
---|---|---|---|
Other names | |||
Grade | Purified | ||
Purity | Purified by proprietary chromatographic technique. ~90% pure (10% SDS-PAGE, Coomassie staining). | ||
Form | Supplied as a liquid in 100mM Tris HCl, pH 8.0, 8M Urea, 200mM sodium chloride. No preservative added | ||
Reactivity life | 12 months | ||
Note | For reserch purpose only | ||
Purity | Purified by proprietary chromatographic technique. ~90% pure (10% SDS-PAGE, Coomassie staining). | ||
Description | Dengue fever is an acute, mosquito-transmitted viral disease characterized by fever, headache, arthralgia (severe retro-orbital pain), myalgia, rash, nausea, and vomiting. Infections are caused by any of the four closely related, but antigenically distinct virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4). Infection with one of these serotypes does not provide cross-protective immunity, so persons living in a dengue-endemic area can have four dengue infections during their lifetimes. Dengue is primarily an urban disease of the tropics, and the viruses that cause it are maintained in a cycle that involves humans and Aedes aegypti, a domestic, day-biting mosquito that prefers to feed on humans. Although most dengue infections result in relatively mild illness, some can produce Dengue Hemorrhagic Fever (DHF) or dengue shock syndrome, with children being particularly at risk. Although epidemic outbreaks have been reported since 1779, the incidence has been increasing, with global, multiple serotype pandemics intensifying within the last 15 years. There is no specific antiviral therapy for dengue, but for both classical dengue and dengue hemorrhagic fever, symptomatic and supportive measures are effective. Important risk factors for DHF include the strain and serotype of the virus involved, as well as the age, immune status, and genetic predisposition of the patient. Description: Recombinant Dengue Virus NS1 protein, full length Type 2 immunodominant regions. Contains a 6-His tag Applications: Suitable for use in ELISA. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
© 2020 Imugex All Rights Reserved